About this trial
Lung cancer is the leading cause of cancer-related death among Veterans with 90% of cases attributable to smoking. Lung cancer screening (LCS) combined with smoking cessation saves the most lives. ICARE-LCS seeks to decrease health inequality and improve Veteran health by reducing smoking rates among Veterans receiving LCS. ICARE-LCS will use implementation methods to inform national cancer prevention efforts and build infrastructure necessary to support broad implementation of high-impact tobacco dependence treatment (TDT) processes in LCS programs.
Eligibility criteria
Qualifiers
This is a VAMC based Quality Improvement Partnered Evaluation Initiative. VA sites from around the country that agreed to participate are included.
Disqualifiers
N/A
Trial design
Treatments tested in this trial
- External Facilitation
Treatment groups
Sponsors and collaborators
VA Office of Research and Development
Lead sponsor
VA Oncology and Precision Medicine
Collaborator
VA Tobacco Use Treatment National Program Office
Collaborator
VA National Center for Lung Cancer Screening
Collaborator